Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4590-4602

  Okon, Imoh S ^a   Coughlan, Kathleen A ^a   Zhang, Cheng ^a   Moriasi, Cate ^a   Ding, Ye ^a   Song, Ping ^a   Zhang, Wencheng ^a,b   Li, Guangpu ^a   Zou, Ming Hui ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN 1; PROTEIN KINASE LKB1; RAB7 PROTEIN; PROTEIN SERINE THREONINE KINASE; RAB PROTEIN; SMALL INTERFERING RNA; STK11 PROTEIN, HUMAN; STK11 PROTEIN, MOUSE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CULTURE; CELL MIGRATION; CELL VACUOLE; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TUMOR GROWTH; ADENOCARCINOMA; AGED; ANIMAL; CELL MEMBRANE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; LUNG; LUNG TUMOR; LYSOSOME; MALE; METABOLISM; MIDDLE AGED; MUTATION; NEOVASCULARIZATION (PATHOLOGY); RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; AGED; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; LYSOSOMES; MALE; MICE; MIDDLE AGED; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-1; PROTEIN-SERINE-THREONINE KINASES; RAB GTP-BINDING PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907481776     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75371     Document Type: Article

References (55)

1. Gurumurthy S, et al. The Lkb1 metabolic sensor maintains haematopoetic stem cell survival. Nature. 2010;468(7324):659-663.
2. Shaw RJ, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell. 2004;6(1):91-99.
3. Lizcano JM, et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004;23(4):833-843.
4. Brugarolas J, Kaelin J W G. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell. 2004;6(1):7-10.
5. Veeranki S, Hwang S, Sun T, Kim B, Kim L. LKB1 regulates development and the stress response in Dictyostelium. Dev Biol. 2011;360(2):351-357.
6. Ylikorkala A, et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science. 2001;293(5533):1323-1326.
7. Ding L, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455(7216):1069-1075.
8. Matsumoto S, et al. Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene. 2007;26(40):5911-5918.
9. Shah U, Sharpless NE, Hayes DN. LKB1 and lung cancer: more than the usual suspects. Cancer Res. 2008;68(10):3562-3565.
10. Zhuang Z, Di G, Shen Z, Ding J, Shao Z. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol Cancer Res. 2006;4(11):843-849.
11. Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene. 2007;26(57):7825-7832.
12. Hongbin J, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature. 2007;448(7155):807-811.
13. Ohashi K, Ouchi N, Higuchi A, Shaw RJ, Walsh K. LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis. J Biol Chem. 2010;285(29):22291-22298.
14. Londesborough A. et al. LKB1 in endothelial cells is required for angiogenesis and TGFβ-mediated vascular smooth muscle cell recruitment. Development. 2008;135(13):2331-2338.
15. Staton CA, Kumar I, Reed M W R, Brown NJ. Neuropilins in physiological and pathological angiogenesis. J Pathol. 2007;212(3):237-248.
16. Bielenberg DR, Pettaway CA, Takashima S, Klaagsbrun M. Neuropilins in neoplasms: expression, regulation, and function. Exp Cell Res. 2006;312(5):584-593.
17. Jubb AM, et al. Neuropilin-1 expression in cancer and development. J Pathol. 2011;226(1):50-60.
18. Ellis LM. The role of neuropilins in cancer. Mol Cancer Ther. 2006;5(5):1099-1107.
19. Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: structure, function and role in disease. Biochem J. 2008;411(2):211-226.
20. Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 2000;14(15):2532-2539.
21. Oh H, et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A. 2002;99(1):383-388.
22. Jia H, et al. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Br J Cancer. 2010;102(3):541-552.
23. Rizzolio S, et al. Neuropilin-1-dependent regulation of EGF-receptor signaling. Cancer Res. 2012;72(22):5801-5811.
24. Zachary IC. How neuropilin-1 regulates receptor tyrosine kinase signaling: the knowns and known unknowns. Biochem Soc Trans. 2011;39(6):1583-1591.
25. Wang L, Mukhopadhyay D, Xu X. C terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis. FASEB J. 2006;20(9):1513-1515.
26. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92(6):735-745.
27. Lee P, et al. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci U S A. 2002;99(16):10470-10475.
28. Douglas H, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86(3):353-364.
29. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401-410.
30. Ballmer-Hofer K, Andersson AE, Ratcliffe LE, Berger P. Neuropilin-1 promotes VEGFR2 trafficking through Rab11 vesicles thereby specifying signal output. Blood. 2011;118(3):816-826.
31. Evans IM, et al. Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells. Mol Cell Biol. 2011;31(6):1174-1185.
32. Zhang M, Chen L, Wang S, Wang T. Rab7: roles in membrane trafficking and disease. Biosci Rep. 2009;29(3):193-209.
33. Cantalupo G, Alifano P, Robert V, Bruni CB, Bucci C. Rab-interacting lysosome protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J. 2001;20(4):683-693.
34. Sun Q, Westphal W, Wong KN, Tan I, Zhong Q. Rubicon controls endosome maturation as a Rab7 effector. Proc Natl Acad Sci U S A. 2010;107(45):19338-19343.
35. Vanlandingham PA, Ceresa BP. Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. J Biol Chem. 2009;284(18):12110-12124.
36. Pfeffer S, Aivazian D. Targeting Rab GTPases to distinct membrane compartments. Nat Rev Mol Cell Biol. 2004;5(11):886-896.
37. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol. 2001;2(2):107-118.
38. Wencheng Z, et al. Endothelial cell-specific liver kinase B1 deletion causes endothelial dysfunction and hypertension in mice in vivo. Circulation. 2014;129(13):1428-1439.
39. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist. 2000;5(suppl 1):3-10.
40. Bae D, Lu S, Taglienti CA, Mercurio A. M. Metabolic stress induces the lysosomal degradation of neuropilin-1 ut not neuropilin-2. J Biol Chem. 2008;283(42):28074-28080.
41. Song P, et al. Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J Biol Chem. 2008;283(18):12446-12455.
42. Xie Y, et al. Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol. 2009;29(13):3582-3596.
43. Boudeau J, et al. MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 2003;22(19):5102-5114.
44. Boudeau J, et al. Analysis of the LKB1-STRAD-MO25 complex. J Cell Sci. 2004;117(pt 26):6365-6375.
45. Alessi DR, Sakamoto K, Bayascas JR. LKB1-dependent signaling pathways. Annu Rev Biochem. 2006;75:137-163.
46. Xu X, Omelchenko T, Hall A. LKB1 tumor suppressor protein regulates actin filament assembly through Rho and its exchange factor Dbl independently of kinase activity. BMC Cell Biol. 2010;11:77.
47. Zhang S, et al. The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Res. 2008;68(3):740-748.
48. Partanen JI, Nieminen AI, Mäkelä TP, Klefstrom J. Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci U S A. 2007;104(37):14694-14699.
49. Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem. 2003;278(33):31000-31006.
50. Basel S, Janice NA, Harold DF. Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res. 2012;72(8):1909-1914.
51. Geretti E, Klagsbrun M. Neuropilins: novel targets for anti-angiogenesis therapies. Cell Adh Migr. 2007;1(2):56-61.
52. Pan Q, et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell. 2007;11(1):53-67.
53. Hong T, Chen Y, Wu Y. Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res. 2007;13(16):4759-4768.
54. Zinchuk V, Zinchuk O, Okada T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem. 2007;40(4):101-111.
55. Quagliata S, Pacini S, Punzi T, Malentacchi C, Ruggiero M, Delfino G. Bombesin promotes vasculogenesis and angiogenesis in chick chorio-allantoic membrane: A morphometric, structural, and ultrastructural study. J Morphol. 2008;269(1):72-83.